FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to solid unit dosage form for pancreatic diabetes. The solid unit dosage form for pancreatic diabetes contains as an active substance a combination of taurine, butadion, metformin, Riboxinum, arginine and gliclazide, as well as targeted additives in the certain ratio.
EFFECT: drug is effective for pancreatic diabetes.
4 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID DOSED FORMULATION FOR TREATMENT OF PANCREATIC DIABETES | 2006 |
|
RU2333760C2 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION OF PROLONGED ACTION | 2011 |
|
RU2465896C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES MELLITUS (VARIANTS) | 2003 |
|
RU2241449C1 |
| COMPOSITION FOR TREATMENT OF DIABETES MELLITUS | 2016 |
|
RU2679602C1 |
| COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES (VERSIONS) | 2010 |
|
RU2483717C2 |
| METHOD AND PHARMACEUTICAL COMPOSITIONS FOR TREATING POSTPRANDIAL HYPERGLYCEMIA ACCOMPANYING TYPE II DIABETES MELLITUS BY ADMINISTERING THROUGH ORAL MUCOSA | 2010 |
|
RU2543635C2 |
| PANCREATIC DIABETES DRUG | 2004 |
|
RU2358738C2 |
| COMBINATIONS AND COMPOSITIONS CONTAINING FATTY ACIDS AND AMINO ACIDS, THEIR APPLICATION FOR PREVENTION AND DELAY OF PROGRESSING OR TREATMENT OF DIABETES AND DIABETES ASSOCIATED DISEASES AND CONDITIONS, METHOD OF WEIGHT REDUCTION IN MAMMAL, KIT | 2004 |
|
RU2356247C2 |
| SOLID MEDICATION | 2003 |
|
RU2357757C2 |
